Related references
Note: Only part of the references are listed.Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Xiao Chen et al.
PHARMACOGENOMICS JOURNAL (2021)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Population Pharmacogenomics for Precision Public Health in Colombia
Shashwat Deepali Nagar et al.
FRONTIERS IN GENETICS (2019)
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R. J. Taylor et al.
LANCET (2019)
Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome
Aaron M. Wenger et al.
NATURE BIOTECHNOLOGY (2019)
Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications
Yusmiati Liau et al.
PHARMACOGENOMICS (2019)
Minimap2: pairwise alignment for nucleotide sequences
Heng Li
BIOINFORMATICS (2018)
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Shehu S. Awandu et al.
MALARIA JOURNAL (2018)
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Audrey Valdes et al.
MALARIA JOURNAL (2018)
Nanopore sequencing and assembly of a human genome with ultra-long reads
Miten Jain et al.
NATURE BIOTECHNOLOGY (2018)
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
Andria L. Del Tredici et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
Andrea Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Prediction of CYP2D6 phenotype from genotype across world populations
Andrea Gaedigk et al.
GENETICS IN MEDICINE (2017)
Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing
Henk P. J. Buermans et al.
HUMAN MUTATION (2017)
Nextflow enables reproducible computational workflows
Paolo Di Tommaso et al.
NATURE BIOTECHNOLOGY (2017)
Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing
Yao Yang et al.
PHARMACOGENOMICS (2017)
Disease burden and the role of pharmacogenomics in African populations
K. L. Mpye et al.
GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS (2017)
Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6
Wanqiong Qiao et al.
HUMAN MUTATION (2016)
Genetic Misdiagnoses and the Potential for Health Disparities
Arjun K. Manrai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art
Sean R. Marcsisin et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Pitfalls of haplotype phasing from amplicon-based long-read sequencing
Thomas W. Laver et al.
SCIENTIFIC REPORTS (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
mixtools: AnRPackage for Analyzing Finite Mixture Models
Tatiana Benaglia et al.
Journal of Statistical Software (2015)
Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru
Salomon Durand et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Jason W. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
Sarah C. Preissner et al.
PLOS ONE (2013)
CYP2D6 update: revised nomenclature for CYP2D7/2D6 hybrid genes
Sarah C. Sim et al.
PHARMACOGENETICS AND GENOMICS (2012)
Frequency of Undetected CYP2D6 Hybrid Genes in Clinical Samples: Impact on Phenotype Prediction
John Logan Black et al.
DRUG METABOLISM AND DISPOSITION (2012)
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1 A GeT-RM and Association for Molecular Pathology Collaborative Project
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays
Anuradha Ramamoorthy et al.
PHARMACOGENETICS AND GENOMICS (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part II
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
Catherine Ciszkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CYP2D6: novel genomic structures and alleles
Whitney E. Kramer et al.
PHARMACOGENETICS AND GENOMICS (2009)
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
M. C. Rebsamen et al.
PHARMACOGENOMICS JOURNAL (2009)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Sequence-based analysis of the CFP2D6*36-CVP2D6*10 tandem-type arrangement, a major CYP2D6*10 haplotype in the Japanese population
Akiko Soyama et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
